Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer ...Middle East

News by : (PR Newswire) -
LUND, Sweden, Oct. 7, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer. Concluding the sample...

Hence then, the article about immunovia has successfully acquired all blood samples required to clinically validate its next generation test for pancreatic cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار